FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

56613007: Bretylium tosylate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
795145012 Bretylium tosylate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2154264013 Bretylium tosilate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2155286016 Bretylium tosylate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
21131000188115 brétylium tosilate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
795591000172117 tosilate de brétylium fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bretylium tosylate (substance) Is a Product containing bretylium (medicinal product) false Inferred relationship Some
Bretylium tosylate (substance) Is a Bretylium (substance) false Inferred relationship Some
Bretylium tosylate (substance) Is a Class II antiarrhythmic agent (substance) true Inferred relationship Some
Bretylium tosylate (substance) Is a Class III antiarrhythmic agent (substance) true Inferred relationship Some
Bretylium tosylate (substance) Is a Quaternary ammonium compound true Inferred relationship Some
Bretylium tosylate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Bretylium (substance) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
tosylate de brétylium 50 mg/mL, seringue préremplie de 10 mL de solution pour injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bretylium tosylate (substance) Inferred relationship Some
Bretylium tosylate 50mg/mL injection solution prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bretylium tosylate (substance) Inferred relationship Some
Bretylium tosylate 50mg/ml injection solution 10mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bretylium tosylate (substance) Inferred relationship Some
Breytlium tosylate 50mg/ml injection solution 200mL bottle The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bretylium tosylate (substance) Inferred relationship Some
Breytlium tosylate 50mg/ml injection solution 50mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bretylium tosylate (substance) Inferred relationship Some
Breytlium tosylate 50mg/ml injection solution 400mL bottle The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bretylium tosylate (substance) Inferred relationship Some
Product containing precisely bretylium tosylate 500 milligram/10 milliliter conventional release solution for injection syringe The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Bretylium tosylate (substance) Inferred relationship Some 1
Product containing precisely bretylium tosylate 500 milligram/10 milliliter conventional release solution for injection syringe This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Bretylium tosylate (substance) Inferred relationship Some 1
Bretylium tosilate 50 mg/mL solution for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Bretylium tosylate (substance) Inferred relationship Some 1
Bretylium tosilate 50 mg/mL solution for injection This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Bretylium tosylate (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start